CRA International, Inc. (CRAI)
NASDAQ: CRAI · Real-Time Price · USD
170.66
-6.00 (-3.40%)
At close: Aug 1, 2025, 4:00 PM
170.16
-0.50 (-0.29%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Revance Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$228.00
Upside
+33.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $224 → $228 | Buy | Maintains | $224 → $228 | +33.60% | May 21, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $212 → $224 | Buy | Maintains | $212 → $224 | +31.26% | Feb 24, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $194 → $212 | Buy | Maintains | $194 → $212 | +24.22% | Nov 8, 2024 |
| Barrington Research | Barrington Research | Buy Reiterates $186 | Buy | Reiterates | $186 | +8.99% | Jun 11, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $151 → $186 | Buy | Maintains | $151 → $186 | +8.99% | May 20, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $117 → $151 | Buy | Maintains | $117 → $151 | -11.52% | Mar 7, 2024 |
| Barrington Research | Barrington Research | Buy Reiterates $133 | Buy | Reiterates | $133 | -22.07% | Aug 8, 2023 |
| Barrington Research | Barrington Research | Buy Reiterates $133 | Buy | Reiterates | $133 | -22.07% | May 12, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $120 → $130 | Buy | Maintains | $120 → $130 | -23.83% | Nov 7, 2022 |
| Barrington Research | Barrington Research | Buy Maintains $115 → $120 | Buy | Maintains | $115 → $120 | -29.68% | Aug 8, 2022 |
| Barrington Research | Barrington Research | Buy Reiterates $130 → $133 | Buy | Reiterates | $130 → $133 | -22.07% | Mar 8, 2022 |